193 related articles for article (PubMed ID: 21706174)
1. Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort.
Brasky TM; Lampe JW; Slatore CG; White E
Cancer Causes Control; 2011 Sep; 22(9):1333-42. PubMed ID: 21706174
[TBL] [Abstract][Full Text] [Related]
2. Use of glucosamine and chondroitin supplements and risk of colorectal cancer.
Kantor ED; Lampe JW; Peters U; Shen DD; Vaughan TL; White E
Cancer Causes Control; 2013 Jun; 24(6):1137-46. PubMed ID: 23529472
[TBL] [Abstract][Full Text] [Related]
3. Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study.
Slatore CG; Au DH; Littman AJ; Satia JA; White E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1203-7. PubMed ID: 19293309
[TBL] [Abstract][Full Text] [Related]
4. Use of glucosamine and chondroitin in relation to mortality.
Bell GA; Kantor ED; Lampe JW; Shen DD; White E
Eur J Epidemiol; 2012 Aug; 27(8):593-603. PubMed ID: 22828954
[TBL] [Abstract][Full Text] [Related]
5. Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study.
Shih C; Hotaling JM; Wright JL; White E
Urol Oncol; 2013 Nov; 31(8):1689-95. PubMed ID: 22795502
[TBL] [Abstract][Full Text] [Related]
6. Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study.
Satia JA; Littman A; Slatore CG; Galanko JA; White E
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1419-28. PubMed ID: 19423520
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.
Brasky TM; Baik CS; Slatore CG; Alvarado M; White E
J Thorac Oncol; 2012 Oct; 7(10):1503-12. PubMed ID: 22982651
[TBL] [Abstract][Full Text] [Related]
8. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.
Brasky TM; Kristal AR; Navarro SL; Lampe JW; Peters U; Patterson RE; White E
Nutr Cancer; 2011; 63(4):573-82. PubMed ID: 21598177
[TBL] [Abstract][Full Text] [Related]
9. Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.
Kantor ED; Zhang X; Wu K; Signorello LB; Chan AT; Fuchs CS; Giovannucci EL
Int J Cancer; 2016 Nov; 139(9):1949-57. PubMed ID: 27357024
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.
Brasky TM; Potter JD; Kristal AR; Patterson RE; Peters U; Asgari MM; Thornquist MD; White E
Cancer Causes Control; 2012 Mar; 23(3):431-44. PubMed ID: 22212612
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.
Brasky TM; Moysich KB; Cohn DE; White E
Gynecol Oncol; 2013 Jan; 128(1):113-119. PubMed ID: 23063765
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study.
Brasky TM; Baik CS; Slatore CG; Potter JD; White E
Lung Cancer; 2012 Aug; 77(2):260-4. PubMed ID: 22608142
[TBL] [Abstract][Full Text] [Related]
13. Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation.
Kantor ED; Lampe JW; Navarro SL; Song X; Milne GL; White E
J Altern Complement Med; 2014 Jun; 20(6):479-85. PubMed ID: 24738579
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin Sulphate and Glucosamine Use Depend on Nonsteroidal Anti-inflammatory Drug Use to Modify the Risk for Colorectal Cancer.
Ibáñez-Sanz G; Guinó E; Morros R; Quijada-Manuitt MÁ; de la Peña-Negro LC; Moreno V
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1809-1816. PubMed ID: 32651216
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.
Harris RE; Beebe-Donk J; Schuller HM
Oncol Rep; 2002; 9(4):693-5. PubMed ID: 12066194
[TBL] [Abstract][Full Text] [Related]
16. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
17. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort.
Brasky TM; White E; Chen CL
J Clin Oncol; 2017 Oct; 35(30):3440-3448. PubMed ID: 28829668
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort.
Brasky TM; Velicer CM; Kristal AR; Peters U; Potter JD; White E
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3185-8. PubMed ID: 20935064
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer risk in relation to dietary acrylamide intake.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
J Natl Cancer Inst; 2009 May; 101(9):651-62. PubMed ID: 19401552
[TBL] [Abstract][Full Text] [Related]
20. Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study.
Ibáñez-Sanz G; Díez-Villanueva A; Vilorio-Marqués L; Gracia E; Aragonés N; Olmedo-Requena R; Llorca J; Vidán J; Amiano P; Nos P; Fernández-Tardón G; Rada R; Chirlaque MD; Guinó E; Dávila-Batista V; Castaño-Vinyals G; Pérez-Gómez B; Mirón-Pozo B; Dierssen-Sotos T; Etxeberria J; Molinuevo A; Álvarez-Cuenllas B; Kogevinas M; Pollán M; Moreno V
Sci Rep; 2018 Feb; 8(1):2040. PubMed ID: 29391578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
